Check out your Company Bowl for anonymous work chats.
Sending Holiday Wishes As we bid farewell to 2022, a year of major achievements in healthcare, we look forward to a New Year full of promise and endless possibilities. But for now, we simply want to say thank you. In the spirit of giving, we’re proud to support local and global charities as well as partner with environmental organizations with the goal of emissions absorption. Here’s to doing even more in 2023… Happy holidays!
September 6, 2022, London, UK – OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access. Steve will report to David Thompson, OPEN Health Evidence & Access CEO, and be responsible for leading the organization’s business development efforts to grow revenue and expand market share. Over the course of a career spanning more than 30 years, Steve has had business development and leadership roles within a wide variety of consultancies, contract research organizations, and real-world data suppliers in the HEOR, RWE, and market access space. Steve is a key hire for the continued growth and success of OPEN Health. Read more from our website.
OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital - The CM Group is a leading medical communications platform offering a set of integrated solutions to US domestic biotech and pharma industry - OPEN Health is one of the leading global providers of scientific communications and market access services helping pharmaceutical companies to unlock the full potential of their clinical and commercial assets London, U.K.; Hingham, MA; Washington, D.C. – July 28, 2022 – OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed Capital (“NaviMed”). The partnership between OPEN Health and The CM Group expands the platform’s global reach and portfolio of best-in-class scientific solutions for the pharma and biotech industry.
OPEN Health has kicked off #pridemonth with various exciting things planned. By supporting inclusiveness and making the most of diversity, we will create a workplace culture where people can thrive.
While the last century has seen a boom in new medicines and healthcare technologies, the fundamental relationship between patients, healthcare professionals and the pharma industry has stayed the same - until the outbreak of Covid-19. The pandemic has made us reevaluate how we access information, driving people to look to digital for answers. Rob Barker, CEO at OPEN Health explains how this has affected pharma: “Covid-19 has changed healthcare in many positive ways: it's increased patient involvement and created a greater need for education and adoption of digital tools. Patients have become increasingly willing to take control of their own healthcare journey.” Go to our website to watch the full video.
March 21, 2022, London, UK – OPEN Health is pleased to announce the appointment of David Thompson, PhD, as Chief Executive Officer for Evidence & Access. David joins OPEN Health with a wealth of global experience in this area. He is a health economist by training, with 25+ years of experience conducting real-world research and HEOR consulting for clients in the biopharmaceutical sector. He was Editor-in-Chief of the ISPOR publication Value & Outcomes Spotlight from 2008 to 2020 and is a current member of the ISPOR Board of Directors. In addition, David serves on the advisory boards and belongs to the working groups of various RWE policy organizations. He is a frequently invited speaker and panelist on HEOR/RWE topics at international conferences and scientific venues, and he has more than 100 abstracts and papers in the peer-reviewed medical literature. In his new role, David will be leading the Evidence & Access practice teams in the HEOR and market access space.
We're proud to launch our Sustainability Report, which highlights the commitments OPEN Health has made and the milestones reached in 2021 to contribute to a sustainable organization. The report provides a snapshot of OPEN Health’s progress in increasing sustainability, illustrating employee-led and company-supported initiatives from 2021. Highlights from our 2021 Sustainability Report include: + Building a Diverse and Inclusive Culture + Our Efforts to Help Improve Our Society + Our Commitment to the Environment + Practicing Good Governance Read the OPEN Health Sustainability Report: https://www.openhealthgroup.com/environmental-social-and-governance
OPEN Health is pleased to announce the appointment of Annemarie Clegg, MD, as Chief Medical Officer and Jennifer Chilver as Chief Commercial Officer of OPEN Health. Annemarie joined OPEN Health in 2018 with Peloton Advantage. Since then, she has been instrumental in building medical affairs consultancy services and driving the growth of the US business as SVP of Strategic Services, and then in expanding the size and capability of the Medical and Scientific Services team as Chief Medical Officer, OPEN Health Communications. As Chief Medical Officer, Annemarie will be responsible for supporting new business, strategic planning, and medical and scientific staff development across the organization. Jennifer joined OPEN Health in 2014, in Succinct Medical Communications, and since that time has provided tremendous leadership and dedication to the company. As Chief Commercial Officer, Jennifer will oversee OPEN Health’s global commercial strategy, marketing, and client growth initiatives in collaboration with the business development and marketing teams.
September 29, 2021, London, UK – OPEN Health is pleased to announce the appointment of Margot Hannah as the new Chief Executive Officer of OPEN Health Communications. Since joining OPEN Health in 2011, Margot has provided tremendous leadership and dedication to the company. She has held numerous positions, most recently as President of the Medical Communications Center of Excellence, where she has been instrumental in building a high-performance team by developing and retaining best-in-class talent. As CEO, she will be responsible for more than 500 people, with overall accountability for the Medical and Brand Communications services, including publications, medical education, learning and development, and creative and digital services. Margot has previously worked for AstraZeneca, Takeda, and Merck, before moving to the agency side in 2007. She believes in harnessing the power of collective expertise, is passionate about talent development, and has a strong track record in effective succession planning.
OPEN Health acquires ARK OPEN Health has announced the acquisition of London-based agency ARK. ARK has a unique approach to delivering data-driven, digital-first creative campaigns. Integrating the ARK business with the OPEN Health Group further strengthens our global creative, digital-first resources, and our ability to offer our global clients measurable omnichannel campaigns.
